Otoferlin Gene-mediated Hearing Loss Natural History Study
Part of paid clinical trials in Iowa City, Iowa.
- Sponsor
- Akouos, Inc.
- Study ID
- NCT05572073
- Status
- Recruiting
Conditions
- Sensorineural Hearing Loss, Bilateral
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 44 Years
- Healthy Volunteers
- Not accepted
Interventions
- Natural History Study — OTHERNatural History Study
Study Details
This is a retrospective and prospective longitudinal study in participants with Otoferlin Gene-Mediated Hearing Loss.
Key Dates
- Start date
- Jul 14, 2022
- Status verified
- Dec 2025
- Primary completion
- Feb 28, 2029
- Completion
- Feb 28, 2029
Study Design
- Enrollment
- 150 participants (estimated)
Arms
- Arm: Retrospective
- Arm: Prospective
Primary Outcome Measure
ABR [ Time Frame: First audiologic data in participant medical record through five-year prospective follow up ]
Central Contacts
- Akouos Clinical Trials+1 857 410 1816
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Iowa | Iowa City | Iowa | 52242 | - |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | - |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | - |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232-8605 | - |
Find similar trials in Iowa City, IA
Related Studies
- Gene Therapy Trial for Otoferlin Gene-mediated Hearing LossPHASE1/PHASE2 · Recruiting · Akouos, Inc. · San Francisco, California
- Cross-sectional and Prospective Study to Characterize Early-onset PresbycusisRecruiting · Sensorion · Tampa, Florida